Ledger.Open graph →
SEC Form D · filed April 5, 2021

Artiva Biotherapeutics, Inc

Offering
$120.0M
Sold
$120.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Diego, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Jennifer J. Bush · San Diego, CAExecBrian J. Daniels · San Diego, CADirectorBong J. Koh · San Diego, CADirectorFred Aslan · San Diego, CAExec · DirectorPeter J. Flynn · San Diego, CAExecLaura J. Stoppel · San Diego, CADirectorThomas J. Farrell · San Diego, CAExecJason J. Litten · San Diego, CAExecJennifer J. Bush · San Diego, CAExecBong J. Koh · San Diego, CADirectorYvonne J. Yamanaka · San Diego, CADirectorYu-Kyeong J. Hwang · San Diego, CADirectorLaura J. Stoppel · San Diego, CADirectorYu-Kyeong J. Hwang · San Diego, CADirectorJason J. Litten · San Diego, CAExecEsther J. Van Den Boom · San Diego, CAExecPeter J. Flynn · San Diego, CAExecEsther J. Van Den Boom · San Diego, CAExecThomas J. Farrell · Houston, TXExecYvonne J. Yamanaka · San Diego, CADirectorYong-Jun J. Huh · San Diego, CADirectorFred Aslan · Sao Paulo, GuernseyExec · DirectorBrian J. Daniels · San Diego, CADirectorYong-Jun J. Huh · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗